RU2014102028A - PRODUCT FOR TREATMENT OF CHILDREN WITH ROTAVIRUS INFECTION AND METHOD OF TREATMENT - Google Patents
PRODUCT FOR TREATMENT OF CHILDREN WITH ROTAVIRUS INFECTION AND METHOD OF TREATMENT Download PDFInfo
- Publication number
- RU2014102028A RU2014102028A RU2014102028/15A RU2014102028A RU2014102028A RU 2014102028 A RU2014102028 A RU 2014102028A RU 2014102028/15 A RU2014102028/15 A RU 2014102028/15A RU 2014102028 A RU2014102028 A RU 2014102028A RU 2014102028 A RU2014102028 A RU 2014102028A
- Authority
- RU
- Russia
- Prior art keywords
- product
- children
- treatment
- rotavirus infection
- biovestin
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
1. Продукт для лечения детей с ротавирусной инфекцией, в качестве которого использована биологически активная добавка - напиток «Биовестин», содержащий бифидобактерии Bifidobacterium adolescentis МС-42 в живой активной форме.2. Способ лечения детей с ротавирусной инфекцией, отличающийся тем, что в традиционную терапию включают биологически активную добавку - напиток «Биовестин», содержащий бифидобактерии Bifidobacterium adolescentis МС-42, при этом лечение проводят на этапе коррекции дисбактериоза кишечника 10-дневным курсом по схеме: детям от 1 года до 3 лет - в дозе 3,0 мл по 2 раза в сутки per os в перерывах между приемами пищи.3. Продукт целесообразно использовать при лечении ротавирусной инфекции у детей раннего возраста на этапе коррекции дисбактериоза кишечника с целью подавления патогенной и условно - патогенной флоры и сокращению сроков заболевания.4. Продукт является эффективным средством, восстанавливающим внутреннюю экологию макроорганизма, что позволяет иммунной системе организма быстрее справляться с вирусной инфекцией.Полученные результаты клинических и лабораторных исследований позволяют считать продукт «Биовестин» как продукт выбора для стартовой коррекции дисбактериоза у больных детей раннего возраста с ротавирусной инфекцией.1. A product for the treatment of children with rotavirus infection, which is used as a biologically active additive - drink "Biovestin" containing bifidobacteria Bifidobacterium adolescentis MS-42 in a live active form. 2. A method of treating children with rotavirus infection, characterized in that the traditional therapy includes a biologically active additive - drink "Biovestin" containing bifidobacteria Bifidobacterium adolescentis МС-42, while the treatment is carried out at the stage of correction of intestinal dysbiosis with a 10-day course according to the scheme: children from 1 year to 3 years - at a dose of 3.0 ml 2 times a day per os in between meals. 3. The product should be used in the treatment of rotavirus infection in young children at the stage of correction of intestinal dysbiosis in order to suppress pathogenic and conditionally pathogenic flora and reduce the duration of the disease. The product is an effective tool that restores the internal ecology of the macroorganism, which allows the body’s immune system to cope with a viral infection faster. The results of clinical and laboratory studies allow us to consider the product "Biovestin" as the product of choice for the initial correction of dysbacteriosis in young children with rotavirus infection.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014102028/15A RU2564899C2 (en) | 2014-01-22 | 2014-01-22 | Method of treating children suffering from rotavirus infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014102028/15A RU2564899C2 (en) | 2014-01-22 | 2014-01-22 | Method of treating children suffering from rotavirus infection |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014102028A true RU2014102028A (en) | 2015-07-27 |
RU2564899C2 RU2564899C2 (en) | 2015-10-10 |
Family
ID=53761844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014102028/15A RU2564899C2 (en) | 2014-01-22 | 2014-01-22 | Method of treating children suffering from rotavirus infection |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2564899C2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2264456C1 (en) * | 2004-04-09 | 2005-11-20 | Государственное Учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габрического МЗ РФ" | Probiotic biopreparation for treatment of various infections and disbiosis and method for therapy of infections and disbiosis |
RU2329651C2 (en) * | 2006-04-18 | 2008-07-27 | Закрытое акционерное общество "Био-Веста" | Fermented milk product and method of its manufacturing (versions) |
RU2353377C2 (en) * | 2007-02-15 | 2009-04-27 | Государственное учреждение Научный центр клинической и экспериментальной медицины Сибирского отделения Российской академии медицинских наук (ГУ НЦКЭМ СО РАМН) | Method of undifferentiated connective displasy correction |
RU2397773C1 (en) * | 2009-03-13 | 2010-08-27 | Общество с ограниченной ответственностью "Читинская медицинская компания" | Method of treating intestinal dysbacteriosis |
RU2489157C1 (en) * | 2012-04-12 | 2013-08-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИЭМ" СО РАМН) | Method of drug-free therapy of patients with chronic gastrointestinal diseases |
-
2014
- 2014-01-22 RU RU2014102028/15A patent/RU2564899C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2564899C2 (en) | 2015-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018009917A (en) | Zika virus vaccine. | |
EA201690905A1 (en) | SPECIFIC ANTIBODIES AGAINST CD38 FOR THE TREATMENT OF MALIGNANT NOROVATION IN HUMAN | |
EA201800564A1 (en) | AKKERMANSIA GLYCANIPHILUS STRAIN, COMPOSITION CONTAINING STRAIN, USING STRAIN AND COMPOSITION, A METHOD OF INCREASING THE AKKERMANSIA GLYCANIPHILUS STRAIN IN THE GASTROUS AND INTESTINAL ZONE | |
EA201892190A1 (en) | TREATMENT OF PSORIASIS WITH ANTI-BODY TO IL-12 AND / OR IL-23 WITH THE GROWTH OF THE INTERVAL BETWEEN THE INTRODUCTION OF DOSE | |
MY201105A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
EA201791199A1 (en) | METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
MX2014004814A (en) | Compounds and methods for enhancing innate immune responses. | |
MX2021002321A (en) | Novel methods. | |
WO2016029136A8 (en) | 3-amidobenzamides and uses thereof for increasing cellular levels of a3g | |
EA201790563A8 (en) | APPLICATION OF WOODLIZUMAB FOR THE TREATMENT OF EOSINOPHIL ASTHMA WITH A DEGREE OF DIFFERENCE TO HEAVY | |
EA201692111A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES | |
MX2021005421A (en) | C11-cyclic substituted 13-membered macrolides and uses thereof. | |
EA202091308A1 (en) | MODIFIED BRUCELLA VACCINE STRAIN FOR THE TREATMENT OF BRUCELLOSIS | |
PH12017500617A1 (en) | Dosage regimen for pegylated interferon | |
RU2014117294A (en) | 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE | |
RU2013154564A (en) | METHODS AND COMPOSITIONS FOR STIMULATING GROWTH OF AN OIL-FREE BODY WEIGHT | |
JP2015044878A5 (en) | ||
RU2014102028A (en) | PRODUCT FOR TREATMENT OF CHILDREN WITH ROTAVIRUS INFECTION AND METHOD OF TREATMENT | |
RU2014120624A (en) | METHOD FOR TREATING A STROKE | |
WO2020112847A3 (en) | Immune supplement composition | |
RU2013154562A (en) | METHODS AND COMPOSITIONS FOR PRESERVING THE BEAUTY BODY WEIGHT IN THE PROCESS OF SLIMMING | |
RU2009119225A (en) | METHOD OF TREATMENT AND PREVENTION OF COCKIDIOSIS OF MINK | |
MX2021015494A (en) | Quinazoline prodrugs for the treatment of viral infections and further diseases. | |
RU2017119949A (en) | A method for the treatment of stenotic forms of Crohn's disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner |